These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 6084088)
1. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund's complete adjuvant. Mitsuzawa E; Yasuda T; Tamura N; Ohtani S Jpn J Exp Med; 1984 Jun; 54(3):97-107. PubMed ID: 6084088 [TBL] [Abstract][Full Text] [Related]
2. Experimental allergic encephalomyelitis induced by basic protein with synthetic adjuvant in comparison with Freund's complete adjuvant. Role of antibodies in correlation with the clinicopathological features. Mitsuzawa E; Yasuda T; Tamura N; Ohtani S J Neurol Sci; 1981 Oct; 52(1):133-45. PubMed ID: 6170738 [TBL] [Abstract][Full Text] [Related]
3. Acute demyelination in EAE after pretreatment with foreign protein and muramyl dipeptide (MDP). Colover J Prog Clin Biol Res; 1984; 146():37-42. PubMed ID: 6718428 [No Abstract] [Full Text] [Related]
4. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant. Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517 [TBL] [Abstract][Full Text] [Related]
5. Protection against experimental allergic encephalomyelitis with peptides derived from myelin basic protein: presence of intact encephalitogenic site is essential. Driscoll BF; Kies MW; Alvord EC J Immunol; 1976 Jul; 117(1):110-4. PubMed ID: 58930 [TBL] [Abstract][Full Text] [Related]
6. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody. Akiyama K; Murakami T; Nomaguchi TA; Nagai Y Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789 [No Abstract] [Full Text] [Related]
7. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Bomford R Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282 [TBL] [Abstract][Full Text] [Related]
8. Immunologic activity of myelin basic protein in strain 2 and strain 13 guinea pigs. Kies MW; Driscoll BF; Lisak RP; Alvord EC J Immunol; 1975 Jul; 115(1):75-9. PubMed ID: 50359 [TBL] [Abstract][Full Text] [Related]
9. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein. Raziuddin S; Kibler RF; Morrison DC J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759 [TBL] [Abstract][Full Text] [Related]
10. Clinical suppression of experimental allergic encephalomyelitis by muramyl dipeptide "adjuvant". Root-Bernstein RS; Yurochko F; Westall FC Brain Res Bull; 1986 Oct; 17(4):473-6. PubMed ID: 3779448 [TBL] [Abstract][Full Text] [Related]
12. Antigenicity study of muroctasin. Yamaguchi F; Hattori H; Wagai N; Tsukada W Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797 [TBL] [Abstract][Full Text] [Related]
13. Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant. Hempel K; Freitag A; Freitag B; Endres B; Mai B; Liebaldt G Int Arch Allergy Appl Immunol; 1985; 76(3):193-9. PubMed ID: 2579028 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides. Raziuddin S; Kibler RF; Morrison DC J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621 [TBL] [Abstract][Full Text] [Related]
15. Resistance to the induction of EAE in AO rats: its prevention by the pre-treatment with cyclophosphamide or low dose of irradiation. Mostarica-Stojković M; Petrović M; Lukić ML Clin Exp Immunol; 1982 Nov; 50(2):311-7. PubMed ID: 6185258 [TBL] [Abstract][Full Text] [Related]
16. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant. Holda JH; Silberg D; Swanborg RH J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402 [TBL] [Abstract][Full Text] [Related]
17. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction. Hinrichs DJ; Roberts CM; Waxman FJ J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820 [TBL] [Abstract][Full Text] [Related]
18. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis. Killen JA; Swanborg RH J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781 [TBL] [Abstract][Full Text] [Related]
19. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP). Parant M; Riveau G; Chedid L Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684 [TBL] [Abstract][Full Text] [Related]
20. [Experimental allergic encephalomyelitis--clinical aspects and treatment]. Błaszczyk B Postepy Hig Med Dosw; 1979; 33(1):77-88. PubMed ID: 86987 [No Abstract] [Full Text] [Related] [Next] [New Search]